Drug
Teclistamab (Tec)
Teclistamab (Tec) is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
recruiting4100%
Recent Activity
4 active trials
Showing 4 of 4
recruitingphase_2
GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
NCT05695508
recruitingphase_2
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
NCT07079423
recruitingphase_2
Teclistamab in Previously Treated AL Amyloidosis
NCT06935162
recruitingnot_applicable
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
NCT06699394
Clinical Trials (4)
Showing 4 of 4 trials
NCT05695508Phase 2
GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
NCT07079423Phase 2
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
NCT06935162Phase 2
Teclistamab in Previously Treated AL Amyloidosis
NCT06699394Not Applicable
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4